Algorithme Pharma Selects Verified Clinical Trials (VCT), the Global Clinical Trial Database Registry, to Stop Duplicate Enrollment in Clinical Trials
Garden City, New York (PRWEB) December 04, 2015 -- Algorithme Pharma USA, an Altasciences company, has selected Verified Clinical Trials (VCT), the global clinical trial research subject database registry, to counter attempts at duplicate enrollment in clinical trial research. The majority of phase I units in North America utilize Verified Clinical Trials, making it the largest North American clinical research subject database registry in both early and late phase clinical trials. Algorithme Pharma USA joins a vast network of research sites and pharmaceutical companies on a national and global level to prevent duplicate enrollment in clinical trials.
Simultaneously enrolling in multiple clinical trials, also known as duplicate enrollment in clinical trials, has become a serious problem in the clinical research world, as research volunteers attempt to jump from one study to another without waiting for the appropriate amount of time to lapse between studies. This is typically done in an effort to earn more money or receive free care. By doing this, others are placed at risk including the drug manufacturer, the research site, and, most importantly, the volunteer. Furthermore, this may result in issues with the data quality. Algorithme Pharma USA has taken a major step by choosing the VCT system to stop professional research subjects from duplicate enrollment in clinical trials. Algorithme Pharma USA is committed to volunteer safety and data quality; hence implementing this research subject database registry system to increase safety measures by preventing numerous protocol deviations.
Dr. Mitchell Efros, CEO of VCT, stated, “Algorithme Pharma USA is the first clinical research unit in North Dakota to utilize a research subject database registry to prevent duplicate enrollment in clinical trials. By joining forces with Verified Clinical Trials, Algorithme Pharma USA has made a serious commitment to preventing duplicate enrollment in clinical trials as well as other protocol deviations while promoting subject safety and improving data quality.”
Kerri Weingard, ANP COO, added, “While research subjects do travel long distances on a daily basis, having units in close proximity increases the chances of attempts at duplicate enrollment in clinical trials exponentially. Algorithme Pharma USA has raised their safety and data quality standards to the next level for their research subjects and their clients.
James Carlson, President and CEO at Algorithme Pharma USA, stated, “Having been in the clinical trial research business for over three decades, I am well aware of the issue of duplicate enrollment. Although we have exerted every effort to prevent it, never before have we had such a far reaching tool as offered by Verified Clinical Trials. We look forward to a close working relationship with Verified Clinical Trials.”
About Altasciences:
Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences’ full service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.
Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts duplicate enrollment in clinical trials and defines itself as the world’s leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials, and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and Pharmaceutical Sponsor that prove invaluable with regards to financial and legal issues and liabilities. Verified Clinical Trials prevents several other key protocol deviations. For more information, RSVP to or visit
http://www.verifiedclinicaltrials.com.
Verified Clinical Trials Contact:
Mitchell Efros MD FACS
CEO
Phone: (516) 998-7499
email: drefros(at)verifiedclinicaltrials(dot)com
Mitchell Efros MD FACS, Verified Clinical Trials, http://www.VerifiedClinicalTrials.com, +1 (516) 220-9205, [email protected]
Share this article